Financial agenda

28 March 2018 Publication of the 2017 consolidated accounts
13 June 2018 Annual General Meeting
6 September 2018 Publication of 2018 half-year results

Press releases are distributed after the close of the stock market.
This financial calendar is for indicative purposes only and OSE Immunotherapeutics could change its publication dates should it deem it necessary.

Sign up to receive press releases by email.

Subscribe to our newsletter

Select one or more lists: